Hydrochlorothiazide reduces urinary calcium excretion in a child with Lowe syndrome
- PMID: 26251718
- PMCID: PMC4515903
- DOI: 10.1093/ckj/sfv048
Hydrochlorothiazide reduces urinary calcium excretion in a child with Lowe syndrome
Abstract
There is a growing recognition that children with Lowe syndrome are at risk of nephrocalcinosis and nephrolithiasis from hypercalciuria. Increased fluid intake and correction of metabolic acidosis have remained the focus for intervention but are not always successful. Thiazide diuretics, which reduce urinary calcium excretion, have not been used in these children, due to concerns that (i) they may not work as a result of the underlying tubular abnormalities and (ii) their risk may outweigh the potential benefits they have to offer. Herein we report a child with Lowe syndrome who was successfully treated with thiazides in managing his hypercalciuria.
Keywords: nephrolithiasis; thiazides; tubulopathy; urinary calcium excretion.
References
-
- Charnas LR, Bernardini I, Rader D, et al. Clinical and laboratory findings in the oculocerebrorenal syndrome of Lowe, with special reference to growth and renal function. N Engl J Med 1991; 324: 1318–1325 - PubMed
-
- Scharer K, Manz F. Renal handling of citrate in children with various kidney disorders. Int J Pediatr Nephrol 1985; 6: 79–88 - PubMed
-
- Sliman GA, Winters WD, Shaw DW, et al. Hypercalciuria and nephrocalcinosis in the oculocerebrorenal syndrome. J Urol 1995; 153: 1244–1246 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources